Clinical Trial

Perform® Humeral System - Fracture Study (PFX)

Study acronym: PFX
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study is an international, single arm, multicenter, prospective follow-up, non-significant risk, Post-Market Clinical Follow-up (PMCF), which is designed to collect safety and performance data on commercially available Perform® Fracture. Data collected from this study will be used for purposes, including but not limited to, PMS, peer-reviewed publications, education materials, future regulatory submissions, and/or product development.
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2028-09-01 -> 2026-10-01 2026-04-16
minor Completion pushed: 2033-09-01 -> 2034-09-01 2026-04-16
Trial Details
NCT Number NCT05773352
Lead Sponsor Stryker Trauma and Extremities
Conditions Traumatic Arthropathy of Shoulder, Fracture Humerus, Traumatic Arthritis, Revision of Other Devices if Sufficient Bone Stock Remains
Enrollment 118 participants
Start Date 2023-08-31
Primary Completion 2026-10-01 (estimated)
Study Completion 2034-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-15